E-Scopics Gains FDA Clearance for Ultrasound-Based Liver Multiscanner

FDA cleared E-Scopics' hepatoscope, a quantitative ultrasound device. It combines transient elastography for fibrosis, attenuation imaging for steatosis, and B-mode for morphology in one exam, intended for point-of-care liver assessment.

• The device is a cart-based system integrating multiple ultrasound techniques into a single, non-invasive liver examination.
• Designed for use at the point of care by non-specialists to quantify liver fibrosis and steatosis.
• The manufacturer highlights merging elastography, attenuation imaging, and B-mode, which traditionally require separate systems.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.